We here find increased levels of the key complement component C3 in the CSF of MS patients, which correlate with the degree of clinical disability, as well as one of the most established markers of ongoing neurodegeneration, NFL [31–33]. The gene discussed is NEFL; the disease is myeloid sarcoma.